Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 207, Issue 3, Pages 475-489Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20090831
Keywords
-
Categories
Funding
- Columbia University
- Irene Diamond Foundation
- National Institutes of Health [AI07525]
- National Institutes of Health/NCI [KO8 CA1295470, R01 CA86017]
Ask authors/readers for more resources
The function of microRNAs (miRNAs) in hematopoietic stem cells (HSCs), committed progenitors, and leukemia stem cells (LSCs) is poorly understood. We show that miR-29a is highly expressed in HSC and down-regulated in hematopoietic progenitors. Ectopic expression of miR-29a in mouse HSC/progenitors results in acquisition of self-renewal capacity by myeloid progenitors, biased myeloid differentiation, and the development of a myeloproliferative disorder that progresses to acute myeloid leukemia (AML). miR-29a promotes progenitor proliferation by expediting G1 to S/G2 cell cycle transitions. miR-29a is overexpressed in human AML and, like human LSC, miR-29a-expressing myeloid progenitors serially transplant AML. Our data indicate that miR-29a regulates early hematopoiesis and suggest that miR-29a initiates AML by converting myeloid progenitors into self-renewing LSC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available